The founders of ANBITION are Davide Rosiello, Sandro De Falco and Menotti Ruvo.
Menotti will bring to ANBITION his longstanding experience, matured in both, public and pharmaceutical industry contexts, in the research and development of new bioactive molecules of both synthetic and biological origin.
Davide is the CEO and will bring in the company his 20 years experience and deep knowledge of the biotherapeutic field, the energy and vision of a versatile and far-sighted entrepreneur of the pharma-industry and the organizational and logistic support of BIOVIIIx.
Sandro will bring to ANBITION his longstanding experience in research and development, matured in both public and pharmaceutical industry contexts, in the field of biomedicine, in cellular and molecular biology and in the development of animal models of diseases.
